Streetbeat News

Stock Prices

INVO

INVO BioScience, Inc. (NASDAQ:INVO) stock has surged over 140% in the last month and is continuing its upward momentum, with a nearly 40% increase over the past five days. The trading volume has significantly exceeded the 100-day average, with over 16.4 million shares traded in the session. The rise comes ahead of an expected Schedule TO filing related to an exchange offer for warrants, which is part of a proposed merger with NAYA Biosciences, Inc. The stock's float is 2.444 million shares, with a high short interest of 11.82%.

Portfolio Pulse from Erica Kollmann

November 13, 2023 | 6:18 pm

ALB

LTHM

XOM

Shares of lithium producers Livent Corp (LTHM) and Albemarle Corp (ALB) are trading lower due to Exxon Mobil Corp's (XOM) announcement of entering the lithium production market. Exxon Mobil plans to start lithium production in Arkansas by 2027 and aims to supply enough lithium for over 1 million EVs per year by 2030. The news has positively impacted Exxon Mobil's shares, while Livent and Albemarle are experiencing selling pressure.

Portfolio Pulse from Adam Eckert

November 13, 2023 | 6:17 pm

KGS

Truist Securities analyst Neal Dingmann has reaffirmed a Buy rating on Kodiak Gas Services (NYSE:KGS) and increased the price target from $24 to $25. This adjustment reflects a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 6:15 pm

GE

General Electric (NYSE:GE) has seen a 12.5% decrease in short interest since its last report, with 7.60 million shares sold short, representing 0.7% of its float. The current short interest is below the peer group average of 1.77%. While a decrease in short interest can indicate a more bullish sentiment, it does not necessarily predict a near-term rise in stock price.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 6:15 pm

CAT

Caterpillar Inc. (NYSE:CAT) has experienced a 7.44% increase in short interest since its last report, with 6.61 million shares sold short, representing 1.3% of its float. It would take about 1.7 days to cover all short positions. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a near-term price drop. Caterpillar's short interest is below its peer group average of 4.31%.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 6:15 pm

GWW

W.W. Grainger (NYSE:GWW) has seen a 14.29% decrease in short interest since its last report, with 824 thousand shares sold short, representing 2.1% of its float. The average time to cover these short positions is 2.71 days. A decrease in short interest can indicate a more bullish sentiment towards the stock. Compared to its peers, GWW has a lower short interest as a percentage of float, with the peer group average at 4.37%.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 6:15 pm

CRWD

Truist Securities analyst Joel Fishbein has reaffirmed a Buy rating on CrowdStrike Holdings (NASDAQ:CRWD) and increased the price target from $200 to $230.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 6:10 pm

SPCB

SuperCom (NASDAQ:SPCB) is expected to release its quarterly earnings report on Tuesday, 2023-11-14, with analysts estimating an EPS of $0.00. Investors are looking for an earnings beat and positive guidance for future growth. Historically, SuperCom's stock price has been volatile post-earnings, with a 14.7% drop after last quarter's beat. Over the past year, SPCB shares have declined by 84.15%, indicating potential concern among long-term shareholders ahead of the earnings announcement.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 6:02 pm

TBLT

ToughBuilt Industries (NASDAQ:TBLT) is scheduled to release its quarterly earnings report on Tuesday, 2023-11-14, with analysts expecting an EPS of $-0.46. Investors are looking for an earnings beat and positive guidance for future growth. Historical performance shows a pattern of stock price decline following earnings misses. Shares are currently trading at $0.172, down 94.44% over the last 52 weeks, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 6:02 pm

EGRX

Eagle Pharmaceuticals (NASDAQ: EGRX) is scheduled to release its quarterly earnings report on November 14, 2023. Analysts predict an EPS of $1.06. Investors are looking for an earnings beat and positive guidance for future growth. Historically, the company's stock price has been sensitive to earnings performance and guidance. Last quarter, EGRX beat the EPS estimate but experienced a 15.95% share price drop the following day. Over the past year, the stock has declined by 74.43%, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 6:02 pm